Impact BioMedical, Inc. IBO 深 沪
交易中 03-26 10:46:08 美东时间
0.5723
-0.010
-1.80%
华盛通- 最 高0.5903
- 今 开0.5632
- 成交量 3.38万股
- 最 低 0.556
- 昨 收 0.5828
- 总市值 5987.47万
- 52周最高 1.95
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 0.3621
- 委 比 33.33%
- 总股本 1.05亿
- 历史最高 6.17
- 量 比 0.12
- 振 幅 5.89%
- 历史最低 0.3621
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Paranovus Entertainment Technology Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
PAVS stock rose 65.6% in pre-market trading after ending sales agreement with A.G.P/Alliance Global Partners and other stocks moved.
03-24 17:31
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Fr...
03-21 05:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Impact BioMedical (AMEX:IBO) shares rose 70.2% to $0.7 during Thursday...
03-05 20:05
Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why
Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio Labs.
03-05 12:38
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
2025-11-20 05:07
Universal Ibogaine Inc. to File Clinical Trial Application for Ibogaine Treatment
Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an update. Universal Ibogaine ...
2025-09-05 07:37
Impact Biomedical announces 3F US patent issue
Impact Biomedical (NYSE:IBO) announced on Monday that the US Patent and Trademark Office has issued a patent titled “Composition and Method of Controlling Infectious Diseases with Functional Fragrance...
2025-08-18 21:07
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
Impact Biomedical Inc. (IBO) announces the issuance of U.S. Patent No. 12,357,584 B2 for a method and composition using plant-derived functional fragrances to control infectious diseases. This invention, developed under IBO’s 3F™ technology platform, demonstrates potential as an antibacterial and antiviral agent, with applications against pathogens like E. coli, MRSA, influenza, and more. The patent expands IBO’s portfolio and underscores its com...
2025-08-18 12:30
Impact BioMedical Q2 EPS $(1.18), Sales $7.00K
Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this quarter.
2025-08-15 05:48
Impact BioMedical Finalizes Debt Conversion Agreement
An update from Impact BioMedical, Inc. ( ($IBO) ) is now available. On July 21,...
2025-07-28 23:30
